{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:56:30Z","timestamp":1767650190071,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Previous rat toxicity studies of <jats:italic>alpha<\/jats:italic>-glycosyl isoquercitrin (AGIQ), a water-soluble flavonol glycoside derived from rutin, revealed systemic yellow bone discoloration. This investigative study was conducted to determine the AGIQ metabolite(s) responsible for the discoloration. Female Sprague\u2013Dawley rats were administered dietary AGIQ at doses of 0%, 1.5%, 3.0%, or 5.0% (0, 1735.0, 3480.8, and 5873.7\u00a0mg\/kg\/day, respectively) for 14\u00a0days, followed by a 14- or 28-day recovery period. Measurements of quercetin in urine and quercetin, quercetin 3-O-glucuronide, kaempferol, and 3-o-methylquercetin metabolites of AGIQ in bone (femur), white and brown fat, and cerebrum samples were conducted following the exposure period and each recovery period. Gross examination of the femur revealed yellow discoloration that increased in intensity with dose and was still present in a dose-related manner following both recovery periods. Quercetin, at levels correlating with AGIQ dose, was measured in the urine following the 14-day exposure period and, at lower concentrations, 14 or 28\u00a0days following cessation of AGIQ exposure. All four metabolites were present in a dose-dependent manner in the femur following 14\u00a0days of dietary exposure; only quercetin, quercetin 3-O-glucuronide, and 3-o-methylquercetin were present during the recovery periods. Quercetin, quercetin 3-O-glucuronide, and 3-o-methylquercetin were detected in white fat (along with kaempferol), brown fat (excluding quercetin due to analytical interference), and cerebrum samples, indicating systemic availability of the metabolites. Collectively, these data implicate quercetin, quercetin 3-O-glucuronide, or 3-o-methylquercetin (or a combination thereof) as the most likely metabolite of AGIQ causing the yellow discoloration of bone in rats administered dietary AGIQ.<\/jats:p>","DOI":"10.1007\/s00204-020-02760-z","type":"journal-article","created":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T20:02:44Z","timestamp":1589054564000},"page":"2413-2421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Identification of compound causing yellow bone discoloration following alpha-glycosyl isoquercitrin exposure in Sprague\u2013Dawley rats"],"prefix":"10.1007","volume":"94","author":[{"given":"Jeffrey P.","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0653-3484","authenticated-orcid":false,"given":"Robert R.","family":"Maronpot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Recio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shim-mo","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,9]]},"reference":[{"key":"2760_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/CAD.0b013e32832d1149","volume":"20","author":"NG Amado","year":"2009","unstructured":"Amado NG, Cerqueira DM, Menezes FS, da Silva JF, Neto VM, Abreu JG (2009) Isoquercitrin isolated from Hyptis fasciculata reduces glioblastoma cell proliferation and changes beta-catenin cellular localization. Anticancer Drugs 20:543\u2013552","journal-title":"Anticancer Drugs"},{"issue":"20","key":"2760_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/0973-7847.194044","volume":"10","author":"AVA David","year":"2016","unstructured":"David AVA, Arulmoli R, Parasuraman S (2016) Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacogn Rev 10(20):84\u201389","journal-title":"Pharmacogn Rev"},{"key":"2760_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s002280000197","volume":"56","author":"I Erlund","year":"2000","unstructured":"Erlund I, Kosonen T, Alfthan G, Maenpaa J, Perttunen K, Kenraali J, Parantainen J, Aro A (2000) Pharmacokinetics of quercitin from quercitin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 56:545\u2013553","journal-title":"Eur J Clin Pharmacol"},{"key":"2760_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jep.2010.12.026","volume":"134","author":"A Gasparotto Junior","year":"2011","unstructured":"Gasparotto Junior A, Gasparotto FM, Lourenco EL, Crestani S, Stefanello ME, Salvador MJ, da Silva-Santos JE, Marques MC, Kassuya CA (2011) Antihypertensive effects of isoquercitrin and extracts from Tropaeolum majus L.: evidence for the inhibition of angiotensin converting enzyme. J Ethnopharmacol 134:363\u2013372","journal-title":"J Ethnopharmacol"},{"key":"2760_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.fct.2003.10.006","volume":"42","author":"M Hasumura","year":"2004","unstructured":"Hasumura M, Yasuhara K, Tamura T, Imai T, Mitsumori K, Hirose M (2004) Evaluation of the toxicity of enzymatically decomposed rutin with 13-weeks dietary administration to Wistar rats. Food Chem Toxicol 42:439\u2013444","journal-title":"Food Chem Toxicol"},{"key":"2760_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.fct.2017.12.059","volume":"113","author":"CA Hobbs","year":"2018","unstructured":"Hobbs CA, Koyanagi M, Swartz C, Davis J, Kasamoto S, Maronpot R, Recio L, Hayashi S (2018) Comprehensive evaluation of the flavonol anti-oxidants, alpha-glycosyl isoquercitrin and isoquercitrin, for genotoxic potential. Food Chem Toxicol 113:218\u2013227","journal-title":"Food Chem Toxicol"},{"key":"2760_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0014-5793(97)01367-7","volume":"418","author":"PCH Hollman","year":"1997","unstructured":"Hollman PCH, van Trijp JMP, Buysman MNCP, Gaag MS, Mengelers MJB, de Vries JHM, Katan MB (1997) Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 418:152\u2013156","journal-title":"FEBS Lett"},{"key":"2760_CR8","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"Institute of Laboratory Animal Resources (ILAR)","year":"2011","unstructured":"Institute of Laboratory Animal Resources (ILAR) (2011) Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington"},{"issue":"10","key":"2760_CR9","first-page":"931","volume":"36","author":"Y Ishikura","year":"2008","unstructured":"Ishikura Y, Fujii W, Sakakibara Y, Kitogo T, Katagiri Y, Oki M (2008) Safety evaluation of excessive intake of the drink containing Japanese pagoda tree polyphenol (enzymatically modified isoquercitrin) in healthy adults include obesity persons. Jpn Pharmacol Ther 36(10):931\u2013939","journal-title":"Jpn Pharmacol Ther"},{"key":"2760_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.antiviral.2010.08.016","volume":"88","author":"Y Kim","year":"2010","unstructured":"Kim Y, Narayanan S, Chang KO (2010) Inhibition of influenza virus replication by plant-derived isoquercetin. Antivir Res 88:227\u2013235","journal-title":"Antivir Res"},{"key":"2760_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00210-011-0613-2","volume":"383","author":"R Li","year":"2011","unstructured":"Li R, Yuan C, Dong C, Shuang S, Choi MM (2011) In vivo antioxidative effect of isoquercitrin on cadmium-induced oxidative damage to mouse liver and kidney. Naunyn Schmiedeb Arch Pharmacol 383:437\u2013445","journal-title":"Naunyn Schmiedeb Arch Pharmacol"},{"key":"2760_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0014-5793(97)00467-5","volume":"409","author":"C Manach","year":"1997","unstructured":"Manach C, Morand C, Demigne C, Texier O, Regerat F, Remesy C (1997) Bioavailability of rutin and quercitin in rats. FEBS Lett 409:12\u201316","journal-title":"FEBS Lett"},{"key":"2760_CR13","first-page":"1","volume":"3","author":"RR Maronpot","year":"2019","unstructured":"Maronpot RR, Ramot Y, Koyanagi M, Dias N, Cameron D, Eniola S, Nyska A, Hayashi S (2019) Ten-day and four-week toxicity and toxicokinetics studies of alpha-glycosyl isoquercitrin in juvenile G\u00f6ttingen minipigs. Toxicol Res App 3:1\u20139","journal-title":"Toxicol Res App"},{"key":"2760_CR14","unstructured":"Ministry of Health and Welfare (MHW) (2014) List of existing food additives. https:\/\/www.ffcr.or.jp\/en\/tenka\/list-of-existing-food-additives\/list-of-existing-food-additives.html. Accessed 25 Jun 2019."},{"key":"2760_CR15","unstructured":"National Toxicology Program (1992) NTP Technical Report on the Toxicology and Carcinogenesis Studies of Quercetin (CAS No. 117\u201339\u20135) in F344\/N Rats (Feed Studies). NTP TR 409; NIH Publication No. 92\u20133140"},{"key":"2760_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.fct.2016.09.030","volume":"97","author":"A Nyska","year":"2016","unstructured":"Nyska A, Hayashi S, Koyanagi M, Davis JP, Jokinen MP, Ramot Y, Maronpot RR (2016) Ninety-day toxicity and single-dose toxicokinetics study of alpha-glycosyl isoquercitrin in Sprague-Dawley rats. Food Chem Toxicol 97:354\u2013366","journal-title":"Food Chem Toxicol"},{"key":"2760_CR17","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.fct.2004.07.010","volume":"42","author":"EI Salim","year":"2004","unstructured":"Salim EI, Kaneko M, Wanibuchi H, Morimura K, Fukushima S (2004) Lack of carcinogenicity of enzymatically modified isoquercitrin in F344\/DuCrj rats. Food Chem Toxicol 42:1949\u20131969","journal-title":"Food Chem Toxicol"},{"key":"2760_CR18","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.fct.2004.11.012","volume":"43","author":"RL Smith","year":"2005","unstructured":"Smith RL, Cohen SM, Doull J, Feron VJ, Goodman JI, Marnett LJ, Munro IC, Portoghese PS, Waddell WJ, Wagner BM, Adams TB, Expert Panel of the F, Extract Manufacturers A (2005) Criteria for the safety evaluation of flavoring substances. The expert panel of the flavor and extract manufacturers association. Food Chem Toxicol 43:1141\u20131177","journal-title":"Food Chem Toxicol"},{"key":"2760_CR19","first-page":"161","volume":"8","author":"S Tamano","year":"2001","unstructured":"Tamano S, Hatahara Y, Sano M, Hagiwara A, Nakamura M, Wahino T, Imaida K (2001) 13-Week oral toxicity and 4-week recovery study of enzymatically modified isoquercitrin in F344\/DuCrj rats. Jpn J Food Chem 8:161\u2013167","journal-title":"Jpn J Food Chem"},{"key":"2760_CR20","unstructured":"US FDA (2007) Agency Response Letter GRAS Notice No. GRN00220 [Alpha-glycosyl Isoquercitrin]. US Food and Drug Administration Center for Food Safety and Applied Nutrition. https:\/\/www.accessdata.fda.gov\/scripts\/fdcc\/index.cfm?set=GrASNotices&id=220. Accessed 5 Nov 2019."},{"key":"2760_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.fct.2014.03.018","volume":"68","author":"K Valentova","year":"2014","unstructured":"Valentova K, Vrba J, Bancirova M, Ulrichova J, Kren V (2014) Isoquercitrin: pharmacology, toxicology, and metabolism. Food Chem Toxicol 68:267\u2013282","journal-title":"Food Chem Toxicol"},{"issue":"10","key":"2760_CR22","first-page":"919","volume":"36","author":"M Yoshimura","year":"2008","unstructured":"Yoshimura M, Maeda A, Abe K, Ohta H, Kiso Y, Takehara I, Fukuhara I, Sakane N (2008) Body fat reducing effect and safety of the beverage containing polyphenols derived from Japanese pagoda tree (enzymatically modified isoquercitrin) in overweight and obese subjects. Jpn Pharmacol Ther 36(10):919\u2013930","journal-title":"Jpn Pharmacol Ther"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02760-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-020-02760-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02760-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T23:15:52Z","timestamp":1620515752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-020-02760-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,9]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["2760"],"URL":"https:\/\/doi.org\/10.1007\/s00204-020-02760-z","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"type":"print","value":"0340-5761"},{"type":"electronic","value":"1432-0738"}],"subject":[],"published":{"date-parts":[[2020,5,9]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No potential conflict of interest was reported by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}